Anna Hadjihambi obtained her BSc degree in Biochemistry from the University of Warwick and then completed her MSc degree in Neuroscience at UCL. Anna then received her PhD, funded by the prestigious Grand Challenges UCL, which was a collaboration between the departments of Liver and Digestive health and Neuroscience, Physiology and Pharmacology. In 2018 Anna started her postdoctoral fellowship at UNIL, Switzerland. During this time, she investigated the effects of non-alcoholic fatty liver disease on altering cerebral physiology, function, and metabolism, as well as the role of the monocarboxylate transporter-1 in protecting the liver and the brain.

In 2020, Anna joined The Roger Williams Institute of Hepatology in London, as a senior postdoc and sub-team lead starting the Liver-Brain axis group and leading her own research. She is currently investigating cerebral alterations arising due to various types of liver disease, the possible mechanisms behind them, as well as the long-term effects of these conditions on the brain following resolution of liver disease. In addition to hepatic encephalopathy,

Anna is interested and has contributed to various other studies from different disciplines (cardiovascular, pharmacology, neuroscience and physiology). Anna is also a STEM ambassador, Greek Women in STEM Mentor and the co-chair of the ISHEN Translational committee.